Names | |
---|---|
Preferred IUPAC name
Ethyl diazoacetate | |
Other names
Ethyl 2-diazoacetate
2-Diazoacetic acid ethyl ester | |
Identifiers | |
3D model (JSmol)
|
|
ChemSpider | |
ECHA InfoCard | 100.009.828 |
EC Number |
|
PubChem CID
|
|
UNII | |
CompTox Dashboard (EPA)
|
|
| |
| |
Properties | |
C4H6N2O2 | |
Molar mass | 114.10 g/mol |
Appearance | yellow oil |
Density | 1.085 g/cm3 |
Melting point | −22 °C (−8 °F; 251 K) |
Boiling point | 140 to 141 °C (284 to 286 °F; 413 to 414 K) 720 mmHg |
Hazards | |
GHS labelling:[3] | |
Danger | |
H226, H240, H302, H315, H320, H351 | |
P281, P305+P351+P338, P501 | |
NFPA 704 (fire diamond) | |
Safety data sheet (SDS) | Ethyl diazoacetate |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
Ethyl diazoacetate (N=N=CHC(O)OC2H5) is a diazo compound and a reagent in organic chemistry. It was discovered by Theodor Curtius in 1883.[4] The compound can be prepared by reaction of the ethyl ester of glycine with sodium nitrite and sodium acetate in water.
As a carbene precursor, it is used in the cyclopropanation of alkenes.
Although the compound is hazardous, it is used in chemical industry as a precursor to trovafloxacin.[5] Procedures for safe industrial handling have been published.[6]
Another location where EDA was used is in the production of BI-4752, a invented 5-HT2C agonist that is even better than lorcaserin.